These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 30895620)

  • 41. A Meta-Analysis of the Diagnostic Accuracy of Circular RNAs in Digestive System Malignancy.
    Chen Z; Zhang L; Han G; Zuo X; Zhang Y; Zhu Q; Wu J; Wang X
    Cell Physiol Biochem; 2018; 45(3):962-972. PubMed ID: 29428945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Role of Circular RNA in Diagnosis, Development and Durg Resistance of Lung Cancer].
    Chen T; Yang Y
    Zhongguo Fei Ai Za Zhi; 2019 Aug; 22(8):532-536. PubMed ID: 31451145
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Diagnostic rather than prognostic markers-relationship between EpCAM overexpression and lung cancer: a meta-analysis.
    Zhu T; Peng X; Cheng Z; Xing D; Zhang M
    Ann Palliat Med; 2021 Apr; 10(4):4025-4036. PubMed ID: 33832309
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Critical function of circular RNAs in lung cancer.
    Drula R; Braicu C; Harangus A; Nabavi SM; Trif M; Slaby O; Ionescu C; Irimie A; Berindan-Neagoe I
    Wiley Interdiscip Rev RNA; 2020 Sep; 11(5):e1592. PubMed ID: 32180372
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The value of miR-155 as a biomarker for the diagnosis and prognosis of lung cancer: a systematic review with meta-analysis.
    Shao C; Yang F; Qin Z; Jing X; Shu Y; Shen H
    BMC Cancer; 2019 Nov; 19(1):1103. PubMed ID: 31727002
    [TBL] [Abstract][Full Text] [Related]  

  • 46. HE4 expression in lung cancer, a meta-analysis.
    Zhong H; Qian Y; Fang S; Yang L; Li L; Gu W
    Clin Chim Acta; 2017 Jul; 470():109-114. PubMed ID: 28499820
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Diagnostic and prognostic value of blood samples for KRAS mutation identification in lung cancer: a meta-analysis.
    Shen H; Che K; Cong L; Dong W; Zhang T; Liu Q; Du J
    Oncotarget; 2017 May; 8(22):36812-36823. PubMed ID: 28415658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prognostic and diagnostic significance of lncRNAs expression in cervical cancer: a systematic review and meta-analysis.
    Chi S; Shen L; Hua T; Liu S; Zhuang G; Wang X; Zhou X; Wang G; Wang H
    Oncotarget; 2017 Oct; 8(45):79061-79072. PubMed ID: 29108287
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A Systematic Review of tRNA-Derived Small non-Coding RNAs as Diagnostic and Prognostic Markers in Cancer.
    Gao L; Xu L; Wang X
    Technol Cancer Res Treat; 2022; 21():15330338211072989. PubMed ID: 35506562
    [No Abstract]   [Full Text] [Related]  

  • 50. Progress in research on the role of circular RNAs in lung cancer.
    Chen Y; Wei S; Wang X; Zhu X; Han S
    World J Surg Oncol; 2018 Nov; 16(1):215. PubMed ID: 30400981
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The prognostic value of interleukin-17 in lung cancer: A systematic review with meta-analysis based on Chinese patients.
    Wang XF; Zhu YT; Wang JJ; Zeng DX; Mu CY; Chen YB; Lei W; Zhu YH; Huang JA
    PLoS One; 2017; 12(9):e0185168. PubMed ID: 28934305
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnostic value of circRNAs as effective biomarkers in human cardiovascular disease: an updated meta-analysis.
    Zhang Z; Guo R; Wang Y; Huang H; Liu J; Wang C; Wu H; Zou T
    Int J Med Sci; 2022; 19(3):446-459. PubMed ID: 35370465
    [No Abstract]   [Full Text] [Related]  

  • 53. The expression profile and clinic significance of the SIX family in non-small cell lung cancer.
    Liu Q; Li A; Tian Y; Liu Y; Li T; Zhang C; Wu JD; Han X; Wu K
    J Hematol Oncol; 2016 Nov; 9(1):119. PubMed ID: 27821176
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Circular RNAs are Potential Prognostic Markers of Head and Neck Squamous Cell Carcinoma: Findings of a Meta-Analysis Study.
    Nath M; Roy D; Choudhury Y
    Front Oncol; 2022; 12():782439. PubMed ID: 35296016
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Abnormally expressed circular RNAs as novel non-invasive biomarkers for hepatocellular carcinoma: A meta-analysis.
    Jiang YL; Shang MM; Dong SZ; Chang YC
    World J Gastrointest Oncol; 2019 Oct; 11(10):909-924. PubMed ID: 31662829
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Overexpression of MMP Family Members Functions as Prognostic Biomarker for Breast Cancer Patients: A Systematic Review and Meta-Analysis.
    Ren F; Tang R; Zhang X; Madushi WM; Luo D; Dang Y; Li Z; Wei K; Chen G
    PLoS One; 2015; 10(8):e0135544. PubMed ID: 26270045
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CircRNAs: From anonymity to novel regulators of gene expression in cancer (Review).
    Harper KL; Mcdonnell E; Whitehouse A
    Int J Oncol; 2019 Dec; 55(6):1183-1193. PubMed ID: 31661122
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Elevated miR-21 is associated with poor prognosis in non-small cell lung cancer: a systematic review and meta-analysis.
    Yuan Y; Xu XY; Zheng HG; Hua BJ
    Eur Rev Med Pharmacol Sci; 2018 Jul; 22(13):4166-4180. PubMed ID: 30024605
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circular RNA ciRS-7 correlates with advance disease and poor prognosis, and its down-regulation inhibits cells proliferation while induces cells apoptosis in non-small cell lung cancer.
    Yan B; Zhang W; Mao XW; Jiang LY
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(24):8712-8721. PubMed ID: 30575911
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Diagnostic value of circular RNAs in female reproductive system diseases: A PRISMA-compliant meta-analysis.
    Ding J; Lyu Y; Guo N; Wang Q; Li L; Ni G
    Biomed Rep; 2020 Apr; 12(4):171-177. PubMed ID: 32190305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.